Cellular prion protein regulates the motor behaviour performance and anxiety-induced responses in genetically modified mice

Behavioural Brain Research

Volumn 183, Issue 1, 2007, Pages 87-94

  Lobão Soares, Bruno ^a   Walz, Roger ^a,b   Carlotti Jr , Carlos Gilberto ^a   Sakamoto, Américo Ceiki ^a   Calvo, Fabrício ^a   Terzian, Ana Luiza Bernardes ^a   Silva, Juliana Almeida da ^a   Wichert Ana, Lauro ^a   Coimbra, Norberto Cysne ^a   Bianchin, Marino Muxfeldt ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anxiety; Cellular prion protein; Motor behaviour; Open field test; Plus maze test; Rota rod test

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; LOCOMOTION; MALE; MAZE TEST; MOTOR PERFORMANCE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION;

ADAPTATION, PSYCHOLOGICAL; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; EXPLORATORY BEHAVIOR; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; MOTOR SKILLS; PRPC PROTEINS; ROTAROD PERFORMANCE TEST; SPECIES SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 34547860406     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.05.027     Document Type: Article

References (49)

1. Aguzzi A., and Weissmann C. Prion research: the next frontiers. Nature 389 (1997) 795-798
2. Prusiner S.B. Prions. Proc Natl Acad Sci USA 95 (1998) 13363-13383
3. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
4. Martins V.R., Linden R., Prado M.A., Walz R., Sakamoto A.C., Izquierdo I., et al. Cellular prion protein: on the road for functions. FEBS Lett 512 (2002) 25-28
5. Whittington M.A., Sidle K.C., Gowland I., Meads J., Hill A.F., Palmer M.S., et al. Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nat Genet 9 (1995) 197-201
6. Tobler I., Gaus S.E., Deboer T., Achermann P., Fischer M., Rulicke T., et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380 (1996) 639-642
7. Brown D.R. Prion and prejudice: normal protein and the synapse. Trends Neurosci 24 (2001) 85-90
8. Chiti Z., Knutsen O.M., Betmouni S., and Greene J.R. An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease. Neurobiol Dis 22 (2006) 363-373
9. Graner E., Mercadante A.F., Zanata S.M., Forlenza O.V., Cabral A.L., Veiga S.S., et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 76 (2000) 85-92
10. Zanata S.M., Lopes M.H., Mercadante A.F., Hajj G.N., Chiarini L.B., Nomizo R., et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21 (2002) 3307-3316
11. Colling S.B., Collinge J., and Jefferys J.G. Hippocampal slices from prion protein null mice: disrupted Ca(2 + )-activated K + currents. Neurosci Lett 209 (1996) 49-52
12. Mallucci G.R., Ratte S., Asante E.A., Linehan J., Gowland I., Jefferys J.G., et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21 (2002) 202-210
13. Walz R., Amaral O.B., Rockenbach I.C., Roesler R., Izquierdo I., Cavalheiro E.A., et al. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40 (1999) 1679-1682
14. Coitinho A.S., Roesler R., Martins V.R., Brentani R.R., and Izquierdo I. Cellular prion protein ablation impairs behavior as a function of age. Neuroreport 14 (2003) 1375-1379
15. Wong B.S., Liu T., Li R., Pan T., Petersen R.B., Smith M.A., et al. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76 (2001) 565-572
16. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 70 (2003) 83-244
17. McEwen B.S., and Sapolsky R.M. Stress and cognitive function. Curr Opin Neurobiol 5 (1995) 205-216
18. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology (Berl) 163 (2002) 467-476
19. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28 (2004) 239-259
20. Mouillet-Richard S., Pietri M., Schneider B., Vidal C., Mutel V., Launay J.M., et al. Modulation of serotonergic receptor signaling and cross-talk by prion protein. J Biol Chem 280 (2005) 4592-4601
21. Keshet G.I., Ovadia H., Taraboulos A., and Gabizon R. Scrapie-infected mice and PrP knockout mice share abnormal localization and activity of neuronal nitric oxide synthase. J Neurochem 72 (1999) 1224-1231
22. Braissant O., Gotoh T., Loup M., Mori M., and Bachmann C. L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 70 (1999) 231-241
23. Egberongbe Y.I., Gentleman S.M., Falkai P., Bogerts B., Polak J.M., and Roberts G.W. The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59 (1994) 561-578
24. Nico P.B., de-Paris F., Vinade E.R., Amaral O.B., Rockenbach I., Soares B.L., et al. Altered behavioural response to acute stress in mice lacking cellular prion protein. Behav. Brain Res 162 (2005) 173-181
25. Mechiel K.S., and De Boer S.F. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 463 (2003) 163-175
26. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
27. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
28. Wall P.M., and Messier C. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci Biobehav Rev 25 (2001) 275-286
29. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
30. Brown D.R. Prion protein-overexpressing cells show altered response to a neurotoxic prion protein peptide. J Neurosci Res 54 (1998) 331-340
31. Miyamoto M. Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice. Neurosci Lett 402 (2006) 201-204
32. Fanini D., Palumbo G., Giorgi R., and Pantaleoni G. Behavioral effects of PCBs in mice. Behav Pharmacol 1 (1990) 505-510
33. Re L., Rossini F., Re F., Bordicchia M., Mercanti A., Fernandez O.S., et al. Prion protein potentiates acetylcholine release at the neuromuscular junction. Pharmacol Res 53 (2006) 62-68
34. Coitinho A.S., Freitas A.R., Lopes M.H., Hajj G.N., Roesler R., Walz R., et al. The interaction between prion protein and laminin modulates memory consolidation. Eur J Neurosci 24 (2006) 3255-3264
35. Baddeley A., Bueno O., Cahill L., Fuster J.M., Izquierdo I., McGaugh J.L., et al. The brain decade in debate: I. Neurobiology of learning and memory. Braz J Med Biol Res 33 (2000) 993-1002
36. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469
37. Kone B.C. Protein-protein interactions controlling nitric oxide synthases. Acta Physiol Scand 168 (2000) 27-31
38. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., et al. Signal transduction through prion protein. Science 289 (2000) 1925-1928
39. De Araujo J.E., Hasenohrl R.U., Huston J.P., and Brandao M.L. Hyperanxiety produced by periaqueductal gray injection of chondroitin sulphate glycosaminoglycan. Neuroreport 12 (2001) 3081-3084
40. Pan T., Wong B.S., Liu T., Li R., Petersen R.B., and Sy M.S. Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 368 (2002) 81-90
41. Mayer-Sonnenfeld T., Zeigler M., Halimi M., Dayan Y., Herzog C., Lasmezas C.I., et al. The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiol Dis 20 (2005) 738-743
42. Galtrey C.M., and Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 54 1 (2007) 1-18
43. Smith D.G., Davis R.J., Gehlert D.R., and Nomikos G.G. Exposure to predator odor stress increases efflux of frontal cortex acetylcholine and monoamines in mice: comparisons with immobilization stress and reversal by chlordiazepoxide. Brain Res 1114 (2006) 24-30
44. Leite-Panissi C.R., Coimbra N.C., and Menescal-de-Oliveira L. The cholinergic stimulation of the central amygdala modifying the tonic immobility response and antinociception in guinea pigs depends on the ventrolateral periaqueductal gray. Brain Res Bull 60 (2003) 167-178
45. Leussis M.P., and Bolivar V.J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 30 (2006) 1045-1064
46. Brandao M.L., Vianna D.M., Masson S., and Santos J. Neural organization of different types of fear: implications for the understanding of anxiety. Rev Bras Psiquiatr 25 Suppl. 2 (2003) 36-41
47. 2 receptors blockade on fear-induced analgesia elicited by electrical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray. Behav Brain Res 87 (1997) 97-103
48. Schmidt B.J., and Jordan L.M. The role of serotonin in reflex modulation and locomotor rhythm production in the mammalian spinal cord. Brain Res Bull 53 (2000) 689-710
49. Coimbra N.C., de Oliveira R., Freitas R.L., Ribeiro S.J., Borelli K.G., Pacagnella R.C., et al. Neuroanatomical approaches of the tectum-reticular pathways and immunohistochemical evidence for serotonin-positive perikarya on neuronal substrates of the superior colliculus and periaqueductal gray matter involved in the elaboration of the defensive behavior and fear-induced analgesia. Exp Neurol 197 (2006) 93-112